Baicalin protects mice from staphylococcus aureus pneumonia via inhibition of the cytolytic activity of-hemolysin

Journal of Infectious Diseases

Volumn 206, Issue 2, 2012, Pages 292-301

  Qiu, Jiazhang ^a   Niu, Xiaodi ^a   Dong, Jing ^a   Wang, Dacheng ^a   Wang, Jianfeng ^a   Li, Hongen ^a   Luo, Mingjing ^a   Li, Shentao ^b   Feng, Haihua ^a   Deng, Xuming ^a  

^a JILIN UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HEMOLYSIN; BAICALIN;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BINDING SITE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; HEMOLYSIS; IN VIVO STUDY; LUNG ALVEOLUS EPITHELIUM; LUNG LAVAGE; MALE; MOLECULAR DYNAMICS; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SIMULATION; SINGLE DRUG DOSE; STAPHYLOCOCCAL PNEUMONIA; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIAL TOXINS; BINDING SITES; FLAVONOIDS; GENE EXPRESSION REGULATION, BACTERIAL; HEMOLYSIN PROTEINS; HEMOLYSIS; MALE; MICE; MICE, INBRED C57BL; PNEUMONIA, STAPHYLOCOCCAL; PROTEIN BINDING; STAPHYLOCOCCUS AUREUS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84862884568     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis336     Document Type: Article

References (38)

1. Wertheim HF, Melles DC, Vos MC, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005; 5:751-62.
2. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339:520-32.
3. Grundmann H, Aires-De-Sousa M, Boyce J, Tiemersma E. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 2006; 368:874-85.
4. Wunderink RG, Rello J, Cammarata SK, Croos-Dabrera RV, Kollef MH. Linezolid vs vancomycin-analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 2003; 124:1789-97.
5. Schlievert PM, Dinges MM, Orwin PM. Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 2000; 13:16.
6. Cheung AL, Xiong YQ, Willard J, Yeaman MR, Bayer AS. Regulation of Staphylococcus aureus alpha-toxin gene (hla) expression by agr, sarA, and sae in vitro and in experimental infective endocarditis. J Infect Dis 2006; 194:1267-75.
7. Gouaux E. Alpha-Hemolysin from Staphylococcus aureus: an archetype of beta-barrel, channel-forming toxins. J Struct Biol 1998; 121:110-22.
8. Bhakdi S, Tranum-Jensen J. Alpha-toxin of Staphylococcus aureus. Microbiol Rev 1991; 55:733-51.
9. Bubeck Wardenburg J, Patel RJ, Schneewind O. Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infect Immun 2007; 75:1040-4.
10. Bramley AJ, Patel AH, O'Reilly M, Foster R, Foster TJ. Roles of alphatoxin and beta-toxin in virulence of Staphylococcus aureus for the mouse mammary gland. Infect Immun 1989; 57:2489-94.
11. Callegan MC, Engel LS, Hill JM, O'Callaghan RJ. Corneal virulence of Staphylococcus aureus: roles of alpha-toxin and protein A in pathogenesis. Infect Immun 1994; 62:2478-82.
12. Patel AH, Nowlan P, Weavers ED, Foster T. Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement. Infect Immun 1987; 55:3103-10.
13. Rasko DA, Sperandio V. Anti-virulence strategies to combat bacteriamediated disease. Nat Rev Drug Discov 2010; 9:117-28.
14. Cegelski L, Marshall GR, Eldridge GR, Hultgren SJ. The biology and future prospects of antivirulence therapies. Nat Rev Microbiol 2008; 6:17-27.
15. Kimura Y, Yokoi K, Matsushita N, Okuda H. Effects of flavonoids isolated from scutellariae radix on the production of tissue-type plasminogen activator and plasminogen activator inhibitor-1 induced by thrombin and thrombin receptor agonist peptide in cultured human umbilical vein endothelial cells. J Pharm Pharmacol 1997; 49:816-22.
16. De Clercq E. Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection. Med Res Rev 2000; 20:323-49.
17. Cao Y, Mao X, Sun C, et al. Baicalin attenuates global cerebral ischemia/reperfusion injury in gerbils via anti-oxidative and anti-apoptotic pathways. Brain Res Bull 2011; 85:396-402.
18. Adams LS, Seeram NP, Hardy ML, Carpenter C, Heber D. Analysis of the interactions of botanical extract combinations against the viability of prostate cancer cell lines. Evid Based Complement Alternat Med 2006; 3:117-24.
19. Li BQ, Fu T, Yan YD, Baylor NW, Ruscetti FW, Kung HF. Inhibition of HIV infection by baicalin-a flavonoid compound purified from Chinese herbal medicine. Cell Mol Biol Res 1993; 39:119-24.
20. Qiu J, Wang D, Xiang H, et al. Subinhibitory concentrations of thymol reduce enterotoxins A and B and alpha-hemolysin production in Staphylococcus aureus isolates. PLoS One 2010; 5:e9736.
21. Shah S, Stapleton PD, Taylor PW. The polyphenol (-)-epicatechin gallate disrupts the secretion of virulence-related proteins by Staphylococcus aureus. Lett Appl Microbiol 2008; 46:181-5.
22. Song L, Hobaugh MR, Shustak C, Cheley S, Bayley H, Gouaux JE. Structure of staphylococcal alpha-hemolysin, a heptameric transmembrane pore. Science 1996; 274:1859-66.
23. Walker B, Bayley H. Key residues for membrane binding, oligomerization, and pore forming activity of staphylococcal alpha-hemolysin identified by cysteine scanning mutagenesis and targeted chemical modification. J Biol Chem 1995; 270:23065-71.
24. Andreu JM, Schaffner-Barbero C, Gil-Redondo R, et al. Insights into nucleotide recognition by cell division protein FtsZ from a mant-GTP competition assay and molecular dynamics. Biochemistry-Us 2010; 49:10458-72.
25. Pungpo P, Punkvang A, Saparpakorn P, Hannongbua S, Wolschann P, Beyer A. Investigating the structural basis of arylamides to improve potency against M. tuberculosis strain through molecular dynamics simulations. Eur J Med Chem 2010; 45:5585-93.
26. Hanson MR, Chung CL. Antibiotic selection for MRSA: case presentations and review of the literature. J Drugs Dermatol 2009; 8:281-6.
27. Escaich S. Antivirulence as a new antibacterial approach for chemotherapy. Curr Opin Chem Biol 2008; 12:400-8.
28. Recsei P, Kreiswirth B, O'Reilly M, Schlievert P, Gruss A, Novick RP. Regulation of exoprotein gene expression in Staphylococcus aureus by agar. Mol Gen Genet 1986; 202:58-61.
29. Bartlett AH, Foster TJ, Hayashida A, Park PW. Alpha-toxin facilitates the generation of CXC chemokine gradients and stimulates neutrophil homing in Staphylococcus aureus pneumonia. J Infect Dis 2008; 198:1529-35.
30. Schneewind O, Wardenburg JB. Vaccine protection against Staphylococcus aureus pneumonia. J Exp Med 2008; 205:287-94.
31. Ragle BE, Bubeck Wardenburg J. Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia. Infect Immun 2009; 77:2712-8.
32. Gu LQ, Braha O, Conlan S, Cheley S, Bayley H. Stochastic sensing of organic analytes by a pore-forming protein containing a molecular adapter. Nature 1999; 398:686-90.
33. Karginov VA, Nestorovich EM, Schmidtmann F, et al. Inhibition of S. aureus alpha-hemolysin and B. anthracis lethal toxin by betacyclodextrin derivatives. Bioorg Med Chem 2007; 15:5424-31.
34. Ragle BE, Karginov VA, Bubeck Wardenburg J. Prevention and treatment of Staphylococcus aureus pneumonia with a beta-cyclodextrin derivative. Antimicrob Agents Chemother 2010; 54:298-304.
35. Novy P, Urban J, Leuner O, Vadlejch J, Kokoska L. In vitro synergistic effects of baicalin with oxytetracycline and tetracycline against Staphylococcus aureus. J Antimicrob Chemother 2011; 66:1298-300.
36. Cushnie TP, Hamilton VE, Lamb AJ. Assessment of the antibacterial activity of selected flavonoids and consideration of discrepancies between previous reports. Microbiol Res 2003; 158:281-9.
37. Liu IX, Durham DG, Richards RM. Baicalin synergy with beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus and other beta-lactam-resistant strains of S. aureus. J Pharm Pharmacol 2000; 52:361-6.
38. Ohlsen K, Ziebuhr W, Koller KP, Hell W, Wichelhaus TA, Hacker J. Effects of subinhibitory concentrations of antibiotics on alpha-toxin (hla) gene expression of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates. Antimicrob Agents Chemother 1998; 42:2817-23.